New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
October 24, 2012
10:01 EDTNTAP, VMED, CTCM, APD, UTHR, DCI, ATML, CLS, NSC, DD, BUD, ILMNOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: AB InBev (BUD) downgraded to Sell from Neutral at Goldman... Atmel (ATML) downgraded to Neutral from Buy at Nomura... CTC Media (CTCM) downgraded to Hold from Buy at Deutsche Bank... Donaldson (DCI) downgraded to Hold from Buy at Jefferies... DuPont (DD) downgraded to Neutral from Overweight at JPMorgan... Norfolk Southern (NSC) downgraded to Neutral from Buy at Citigroup... United Therapeutics (UTHR) downgraded to Underweight from Neutral at JPMorgan... Virgin Media (VMED) downgraded to Neutral from Buy at Citigroup... Air Products (APD) downgraded to Hold from Buy at KeyBanc... Celestica (CLS) downgraded to Hold from Speculative Buy at Canaccord... NetApp (NTAP) downgraded to Market Perform from Outperform at BMO Capital... United Therapeutics (UTHR) downgraded to Market Perform from Outperform at BMO Capital... Illumina (ILMN) downgraded to Underperform from Outperform at CLSA.
News For BUD;ATML;CTCM;DD;DCI;VMED;NSC;UTHR;NTAP;CLS;APD;ILMN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 >>
August 20, 2015
06:51 EDTNTAPNetApp product growth still a concern, says Piper Jaffray
Subscribe for More Information
05:55 EDTNTAP, ATMLStocks with implied volatility above IV index mean; NTAP ATML
Subscribe for More Information
August 19, 2015
18:34 EDTNTAPOn The Fly: After Hours Movers
Subscribe for More Information
18:08 EDTNTAPNetApp advances after Q1 results and current quarter guidance top estimates
Share of computer data software and systems provider NetApp (NTAP) are advancing after reporting first quarter results that surpassed analyst expectations and provided better than expected guidance for the second quarter. WHAT'S NEW: NetApp reported Q1 profit and revenue that surpassed analysts' average estimates. The company reported Q1 earnings per share of 29c on revenue of $1.34B. Analysts were expecting EPS of 23c on revenue of $1.32B. Looking ahead to Q2, the company expects to report EPS of 55c-60c on revenue of $1.4B-$1.5B. Consensus estimates for Q2 were 46c for EPS and $1.39B for revenue at the time of the report. NetApp CEO George Kurian said, "The IT industry as a whole is going through fundamental change as enterprises transform themselves with digital capabilities. Data is at the heart of these transformations and where NetApp has a profoundly important role to play with our differentiated vision for data management." WHAT'S NOTABLE: On the company's Q1 earnings call, the CEO noted the transformation of IT environments. Customers are reducing their spend on traditional storage "which has put pressure on our ONTAP 7 mode business," Kurian noted. The CEO also pointed out that customers are slowing investment in the capacity expansion of their traditional storage environments. These dynamics put pressure on product revenue despite strong growth in other parts of the business, the CEO said. NetApp sees fiscal year 2016 revenue to be lower by 5% year-over-year as FX headwinds continue along with limited top line predictability. ANALYST TAKE: On August 17, Summit Research analyst Srini Nandury downgraded NetApp to Sell, saying dynamics in the storage industry as well as the company's Cluster ONTAP product transition will make revenue growth "elusive in the near-term." Weaker storage spending and continued problems with getting customers to upgrade to Cluster ONTAP could drive consensus estimates lower from current levels, Nandury told investors in a research note. PRICE ACTION: Shares of NetApp are up 6.75% in after-hours trading, but off their earlier after-hours high.
17:44 EDTNTAPNetApp sees FY16 revenue to down about 5%
Subscribe for More Information
16:05 EDTNTAPNetApp spikes over 15% after reporting Q1 results, guidance
Subscribe for More Information
16:03 EDTNTAPNetApp sees Q2 EPS 55c-60c, consensus 46c
Subscribe for More Information
16:02 EDTNTAPNetApp reports Q1 EPS 29c, consensus 23c
Subscribe for More Information
15:53 EDTNTAPNetApp August 29.5 straddle priced for 5.3% movement into Q1
14:48 EDTNTAPNotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include L Brands (LB), consensus 68c... NetApp (NTAP), consensus 23c... Synopsys (SNPS), consensus 59c... Popeyes Louisiana Kitchen (PLKI), consensus 44c... Semtech (SMTC), consensus 24c.
14:16 EDTNTAPNetApp technical comments ahead of earnings
Subscribe for More Information
13:30 EDTNTAP, DDOptions with increasing put volume;
Subscribe for More Information
12:53 EDTNTAPEarnings Watch: Analysts mostly bearish on NetApp ahead of Q1 earnings
Subscribe for More Information
06:09 EDTUTHRUnited Therapeutics agrees to sell PPRV to AbbVie for $350M
United Therapeutics (UTHR) announced that it has entered into an agreement to sell its Rare Pediatric Disease Priority Review Voucher, or PPRV, to a subsidiary of AbbVie (ABBV). United Therapeutics received the PPRV when Unituxin was approved by the FDA for the treatment of neuroblastoma, a rare pediatric disease. Upon closing of the transaction, United Therapeutics will receive $350M in cash in exchange for the PPRV. The voucher was awarded by the FDA under a provision that encourages development of new drugs and biologics for the prevention and treatment of rare pediatric diseases.
05:55 EDTATMLStocks with implied volatility above IV index mean; ANF ATML
Subscribe for More Information
05:36 EDTILMNIllumina price target raised to $250 from $240 at Mizuho
Subscribe for More Information
August 18, 2015
13:36 EDTNTAPNetApp August volatility elevated into Q1 and outlook
Subscribe for More Information
13:32 EDTATMLAtmel collaborates with Intel on Internet of Things applications
Subscribe for More Information
06:01 EDTATMLStocks with implied volatility above IV index mean; WMB ATML
Subscribe for More Information
05:25 EDTILMNIllumina, Warburg Pincus, Sutter Hill form Helix, announce collaborations
Illumina (ILMN), Warburg Pincus and Sutter Hill Ventures announced that they have formed a company to empower consumers to discover insights into their own genomes through a vibrant ecosystem of high-quality content partners. The company, called Helix, is based in the San Francisco Bay Area and received financing commitments in excess of $100M. Jay Flatley, CEO of Illumina, will serve as chairman. Helix will enable individuals to acquire an unprecedented amount of genetic information by providing affordable sequencing and database services for consumer samples brought through third party partners, driving the creation of an ecosystem of consumer applications. Helix also announced two collaborations today with major partners. First, the Center for Individualized Medicine at Mayo Clinic is collaborating with Helix to develop applications initially focused on consumer education and health-related queries. As part of the collaboration, Mayo Clinic also made a strategic investment in Helix. Second, Laboratory Corporation of America Holdings (LH) will develop and offer innovative analysis and interpretation services, initially focused on medically actionable genetic conditions, to consumers through Helix's platform. Helix expects that other partners will develop applications focused on areas such as genealogy, fitness or wellness, and inherited traits to enable insights related to an individual's genetics.
1 | 2 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use